When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Neuroblastoma

Última revisión: 27 Nov 2025
Última actualización: 17 Jun 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • age ≤4 years
  • abdominal distension
  • abdominal mass
  • pain
  • decreased appetite
  • weight loss
  • fussiness (infants)
  • fatigue
  • periorbital ecchymosis (raccoon eyes)
  • subcutaneous skin nodules
  • family history of neuroblastic tumors
  • signs of spinal cord compression
  • signs of Horner syndrome
  • signs of superior vena cava syndrome
  • intractable secretory diarrhea
  • opsoclonus-myoclonus ataxia (OMA)
Todos los datos

Otros factores de diagnóstico

  • constipation
  • pallor
  • bleeding
  • infections
  • hypertension
  • hepatomegaly
Todos los datos

Factores de riesgo

  • neurocristopathies or other syndromes
  • family history of neuroblastic tumors or genetic predisposition
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • CBC
  • serum electrolytes
  • serum creatinine/BUN
  • LFTs
  • urine catecholamines
  • ultrasound abdomen
  • CT scan
  • MRI scan
  • tumor biopsy
Todos los datos

Pruebas diagnósticas que deben considerarse

  • bilateral bone marrow aspiration and biopsy
  • molecular genetic testing
  • serum LDH
  • serum vasoactive intestinal peptide (VIP)
  • 123-iodine-metaiodobenzylguanidine (MIBG) scintigraphy
  • positron emission tomography with 18-F-deoxyglucose (18F-FDG PET)
Todos los datos

Algoritmo de tratamiento

Agudo

low-risk disease

intermediate-risk disease

high-risk disease

En curso

relapsed or refractory disease

Colaboradores

Autores

Jason Shohet, MD, PhD

Associate Professor

University of Massachusetts

Chan Medical School

Worcester

MA

Divulgaciones

JS is an author of a reference cited in the topic.

Jennifer Foster, MD, MPH

Clinical Director, Neuroblastoma Program

Associate Professor

Department of Pediatrics Section of Hematology/Oncology

Texas Children's Cancer Center

Baylor College of Medicine

Houston

TX

Divulgaciones

JF has served on the advisory board for US WorldMeds. JF is an author of references cited in the topic.

Revisores por pares

Juliet C Gray, MB, BS, MA, MRCPCH, PhD

Associate Professor and Consultant in Paediatric Oncology

University of Southampton

Southampton

UK

Divulgaciones

JCG declares that she has no competing interests.

Daniel Weiser, MD

Medical Director, Intra-Abdominal Solid Tumor Program

Children's Hospital at Montefiore

Assistant Professor, Departments of Pediatrics & Genetics

Albert Einstein College of Medicine

Bronx

NY

Divulgaciones

DW declares that he has no competing interests.

Keri A. Streby, MD

Assistant Professor of Pediatrics

Nationwide Children's Hospital

The Ohio State University

Columbus

OH

Divulgaciones

KS is a consultant for YmAbs Therapeutics, Inc, Amgen, and Illumina Radiopharmaceuticals, Inc.

David Ziegler, MBBS, BSc (Med), FRACP, MD/PhD

Senior Staff Specialist

Sydney Children’s Hospital

Randwick

Sydney

Australia

Divulgaciones

DZ declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011 Oct;261(1):243-57.Texto completo  Resumen

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroblastoma [internet publication].Texto completo

Park JR, Bagatell R, Cohn SL, et al. Revisions to the International Neuroblastoma Response Criteria: a consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-7.Texto completo  Resumen

Irwin MS, Naranjo A, Zhang FF, et al. Revised neuroblastoma risk classification system: a report from the Children's Oncology Group. J Clin Oncol. 2021 Oct 10;39(29):3229-41. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad